Vancouver, British Columbia, October 3, 2026 / PRNewswire / -- According to news reviews, as the quarter changed, large tech stocks drove the Nasdaq Composite Index to a weekly gain, while the Dow Jones Industrial Average and the Russell 2000 Index closed lower on a weekly basis, highlighting that the market gains were more concentrated. Despite a strong performance on Friday, the S&P 500 Index was still below its closing level from the previous week. Volatility eased somewhat, with VIX falling on that day; at the same time, crude oil prices tumbled significantly, and the yield on 10-year U.S. Treasury bonds rose slightly. During this period, several companies announced contract updates, earnings guidance, and merger and acquisition news. Companies with the latest developments this week include: RTX ( NYSE : RTX ), Integra LifeSciences Holdings Corporation ( Nasdaq : IART ), Trilogy Metals Inc ( NYSE American : TMQ ), Phillips Edison & Company, Inc ( Nasdaq : PECO ), and Axogen, Inc ( Nasdaq : AXGN ).

The Dow Jones Industrial Average closed at 51,094.96 points, up 0.33% for the day, but down 1.42% for the week; on the 14th, the Relative Strength Index (RSI) was 38.1, indicating a weakening trend. The S&P 500 Index closed at 7,719.34 points, up 0.69% for the day, but down 0.31% for the week; the Nasdaq Composite Index rose 1.18% to 27,188.02 points, with a weekly increase of 0.44%. The Russell 2000 Index rose 0.97% to 2,833.74 points, but fell 0.13% for the week.

The Volatility Index (VIX) dropped to 15.58, falling 0.81 points on the day and 0.49 points for the week; the Nasdaq 100 Volatility Index closed at 21.93, down 0.58 points on the day but up 1.06 points for the week. Crude oil fell 2.48% on the day and 2.19% for the week, to $90.57 per barrel; natural gas rose 1.69% on the day to $3.02 per million British thermal units.

Gold fell 0.85% on the day to $4,166.60 per ounce, with the weekly trend remaining relatively flat; silver fell 0.53% on the day and 1.33% for the week to $60.40. Copper prices rose 1.07% to $6.55 per pound. The yield on 10-year U.S. Treasury bonds increased by 2 basis points on the day to 5.26% for the week, and the euro declined 0.64% against the dollar.

The complete report also includes the key support and resistance levels for the major indices this week, as well as more company news and market sentiment for the current week.

As mentioned in the original text, for more news regarding RTX ( NYSE : RTX ), Integra LifeSciences Holdings Corporation ( Nasdaq : IART ), Trilogy Metals Inc ( NYSE American : TMQ ), Phillips Edison & Company, Inc ( Nasdaq : PECO ), and Axogen, Inc ( Nasdaq : AXGN ), please refer to:https :// stockpreachers.com / articles / big-tech-carries-the-tape-while-the-dow-limps-to-friday /

It is also mentioned in the text that other industry developments in the market this week include:

RTX ( NYSE : RTX )RTX's Raytheon Company (Raytheon) has secured a five-year contract with two additional option periods, totaling up to $24.4 billion in value. The contract is for the provision of the "Standard-6" interceptor missile (Standard Missile-6), with the aim of enhancing the availability of this multi-mission ammunition for the United States Navy.

Thor's president, Phil Jasper, stated: "The multitasking capabilities of SM-6 are crucial for our customers, and Thor is going all out to meet this demand. By continuously investing in operations and facilities, we are eliminating limitations and increasing production capacity to ensure the delivery of these key capabilities that sailors rely on."

The company stated that SM-6 is the only weapon that has been proven in actual combat to be capable of performing air defense, anti-ship, and ballistic missile defense tasks; the company has also made investments in labor force expansion, industrial cooperation, and automation to support higher production levels.

Integra LifeSciences Holdings Corporation ( Nasdaq : IART )Integra LifeSciences released its preliminary third-quarter results and updated its full-year guidance for 2026, stating that it continues to be affected by the flood event at its Cincinnati plant in July. The company expects revenue for the third quarter to be approximately $410 million to $412 million, with an adjusted diluted earnings per share of $0.55 to $0.59.

Chairman and CEO Stuart Essig stated: "Our third-quarter performance was affected by the flood event at our Cincinnati plant in July. Our team has made significant progress in implementing recovery plans and supporting our customers."

The company has lowered its full-year revenue forecast for 2026 from $1.654 billion to $1.695 billion to $1.634 billion to $1.654 billion; it has also reduced the adjusted earnings per share guidance from $2.40 to $2.50 to $2.30 to $2.40; at the same time, it still expects full-year operating cash flow to be between $190 million and $200 million.

Trilogy Metals Inc. ( NYSE American : TMQ )Trilogy Metals reports that as of August 31, 2026, the company's cash balance was $31.2 million, and the adjusted working capital was $30.3 million; it also announced that on September 11, 2026, it completed a strategic equity investment of $35.6 million from the U.S. Department of War ( Department of War ).

The company reported a net profit of $200,000 in the third quarter, compared to a net loss of $1.7 million in the same period last year; whereas for the first nine months, the net loss was $13.2 million, compared to a net loss of $7.5 million in the same period last year.

President and CEO Tony Giardini stated: "The third quarter, and the weeks that follow, are of transformative significance for Trilogy Metals. With the licensing timeline becoming clear, U.S. government investments in place, and a clear path to obtaining the 'Decision Record', the Arctic project is now well-positioned to become a cornerstone of a secure, domestic copper supply chain."

Phillips Edison & Company, Inc. (Nasdaq : PECO)Phillips Edison reiterated its full-year profit guidance for 2026 and raised the total acquisition guidance from $500 million to $600 million to $600 million to $700 million. The company stated that as of September 30, 2026, it had acquired assets worth $459.7 million and sold assets worth $174.0 million during the year.

The company's reconfirmed median guidance for Nareit FFO per diluted earnings for the full year of 2026 represents a year-on-year increase of 6.3%; the median guidance for Core FFO indicates a year-on-year increase of 6.2%; and the median guidance for same-store net operating revenue (same-center NOI) suggests a year-on-year increase of 3.7%.

Chairman and CEO Jeff Edison stated: "We are pleased to reaffirm our 2026 full-year Core FFO per-share growth guidance, which reflects a year-on-year increase of 6.2%. On this basis, we are still able to maintain a strong balance sheet and adhere to our consistent and prudent investment approach defined by PECO."

Axogen, Inc. (Nasdaq : AXGN)Axogen has completed the acquisition of BioCircuit Technologies, bringing NerveTape under its umbrella. The company stated that NerveTape is the first device to receive approval from the US Food and Drug Administration (FDA) for use in sutureless peripheral nerve repair.

Axogen, President and CEO, Michael Dale stated: "As the first seamless nerve repair solution, NerveTape represents a new standard of care. It is simpler, faster, and more effective than microsurgery."

The company expects that BioCircuit will contribute approximately $6 million in revenue in the fourth quarter of 2026 and about $34 million in revenue in 2027; this contribution is not included in Axogen's guidance for at least a 24% increase in revenue for the entire year of 2026. Axogen still expects a gross margin of at least 73% and to achieve positive free cash flow for the whole year.

Contact Information: